United States

AbbVie Inc. ABBV

NYSE Health technology USD

AbbVie Inc. is a global biopharmaceutical company that discovers, develops, manufactures, and commercializes a broad portfolio of medicines. The company operates across several therapeutic areas, including immunology, oncology, neuroscience, aesthetics, and eye care. AbbVie serves patients and healthcare providers worldwide, with a significant presence in North America, Europe, and other international markets. Its business model is centered on research and development to create innovative therapies, supported by strategic acquisitions and partnerships to expand its product pipeline and commercial reach. The company markets both branded pharmaceuticals and aesthetic products, generating revenue primarily from product sales and collaboration agreements.

Current Price USD 222.99
Daily Change -0.06%
Market Cap USD 394.11 B
Shares Outstanding 1.77 B
Forecast

LSTM Forecast

Forecast model is not trained yet for this market.

Next 5 Trading Days

Train and backfill the LSTM forecast to surface a directional view here.

Chart